Weight-loss drugs like Ozempic and Zepbound impact user behavior and mental health

Weight-loss drugs like Ozempic and Zepbound are reshaping user behavior and mental health beyond their physiological effects. These GLP-1 agonists improve health but also lead to users feeling "normal," highlighting past stigma, and are increasingly sought for aesthetic reasons, risking reinforcement of unhealthy societal pressures. Users endure significant side effects and financial strain, sometimes modifying dosages based on peer advice, raising safety concerns and necessitating a holistic approach to their use.